isatin has been researched along with lead in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bal, TR; Sriram, D; Yogeeswari, P | 1 |
| Ahmadi, S; Faraji, H; Hakimi, M; Mashkani, B; Moghimi Benhangi, H; Molafilabi, A | 1 |
2 other study(ies) available for isatin and lead
| Article | Year |
|---|---|
Aminopyrimidinimino isatin analogues: design and synthesis of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum anti-microbial properties.
Topics: Anti-Infective Agents; Bacteria; Cells, Cultured; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Imines; Indoles; Isatin; Lead; Mycobacterium tuberculosis; Pyrimidines; Quinolines; Reverse Transcriptase Inhibitors; Virus Replication | 2005 |
Protective effects of isatin and its synthetic derivatives against iron, copper and lead toxicity.
Topics: Copper; HEK293 Cells; Humans; Iron; Isatin; Lead; Protective Agents | 2019 |